Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery

被引:0
|
作者
Li, Li [1 ]
Huang, Jia-Ling [1 ]
Liu, Qi-Cai [2 ]
Wu, Pei-Hong [1 ]
Liu, Ran-Yi [1 ]
Zeng, Yi-Xin [1 ]
Huang, Wen-Lin [1 ]
机构
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China
[2] Guangzhou Med Coll, Expt Med Res Ctr, Guangzhou 510182, Guangdong, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the expression of adenovirus-mediated human endostatin (Ad/hEndo) gene transfer and its effect on the growth of hepatocellular carcinoma (HCC) BEL-7402 xenografted tumors. METHODS: Immunohistochemistry analysis with an anti-endostatin antibody was preformed to detect endostatin protein expression in HCC BEL-7402 cells infected with Ad/hEndo. MTT assay was used to investigate the effects of Ad/hEndo on proliferation of human umbilical vein endothelial cells (HUVEC). Intra-tumoral injections of 1x10(9) pfu Ad/hEndo was given to treat BEL-7402 xenografted tumors in nude mice once weekly for 6 wk. Mice received injections of Ad/LacZ and DMEM were regarded as control groups. After intra-turmoral administration with Ad/hEndo, the endostatin mRNA expression in tumor tissue was analyzed by Northern blotting, and plasma endostatin levels were determined using enzyme-linked immunosorbent assay (ELISA). RESULTS: High level expression of endostatin gene was detected in the infected HCC BEL-7402 cells. Ad/hEndo significantly inhibited HUVEC cell proliferation by 57.2% at a multiplicity of infection (MOI) of 20. After 6-week treatment with Ad/hEndo, the growth of treated tumors was inhibited by 46.50% compared to the Ad/LacZ control group (t=2.729, P<0.05) and by 48.56% compared to the DMEM control group (t=2.485, P<0.05). The ratio of mean tumor volume in treated animals to mean tumor volume in the control animals (T:C ratio) was less than 50% after 24 d of treatment. Endostatin mRNA in tumor tissue was clearly demonstrated as a band of approximately 1.2 kb, which was the expected size of intact and functional endostatin. Plasma endostatin levels peaked at 87.52 +/- 8.34 ng/mL at d 3 after Ad/hEndo injection, which was significantly higher than the basal level (12.23 +/- 2.54 ng/mL). By d 7, plasma levels dropped to nearly half the peak level (40.34 +/- 4.80 ng/mL). CONCLUSION: Adenovirus-mediated human endostatin gene can successfully express endogenous endostatin in vitro and in vivo, and significantly inhibit the growth of BEL-7402 xenografted liver tumors in nude mice.
引用
收藏
页码:1867 / 1871
页数:5
相关论文
共 50 条
  • [1] Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery
    Li Li Jia-Ling Huang Ran-Yi Liu Pei-Hong Wu Yi-Xin Zeng Wen-Lin Huang Cancer Center
    World Journal of Gastroenterology, 2004, (13) : 1867 - 1871
  • [2] Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice
    Feldman, AL
    Restifo, NP
    Alexander, HR
    Bartlett, DL
    Hwu, P
    Seth, P
    Libutti, SK
    CANCER RESEARCH, 2000, 60 (06) : 1503 - 1506
  • [3] Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer
    Geng-Feng Fu
    Xi Li
    Ya-Yi Hou
    Yan-Rong Fan
    Wen-Hua Liu
    Gen-Xing Xu
    Cancer Gene Therapy, 2005, 12 : 133 - 140
  • [4] Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer
    Fu, GF
    Li, X
    Hou, YY
    Fan, YR
    Liu, WH
    Xu, GX
    CANCER GENE THERAPY, 2005, 12 (02) : 133 - 140
  • [5] Compared stability and antitumour activity of recombinant endostatin protein expressed in yeast with recombinant adenovirus carrying endostatin gene
    Liang, ZH
    Huang, JL
    Huang, WL
    MOLECULAR THERAPY, 2004, 9 : S296 - S297
  • [6] Delivery of endostatin in experimental cancer therapy
    Sorensen, DR
    Read, TA
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2002, 83 (06) : 265 - 274
  • [7] Effective systemic adenovirus-mediated endostatin gene therapy in a colorectal liver metastases model
    Maron
    Xie
    Choi
    Lei
    Wilson
    Fraker
    Spitz, F
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : S45 - S45
  • [8] Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy
    Watanabe, Maki
    Nishikawaji, Yuya
    Kawakami, Hirotaka
    Kosai, Ken-ichiro
    VIRUSES-BASEL, 2021, 13 (12):
  • [9] Gene Therapy with Recombinant Adenovirus Encoding Endostatin Encapsulated in Cationic Liposome in Coxsackievirus and Adenovirus Receptor-Deficient Colon Carcinoma Murine Models
    Wang, Lian
    Yao, Bin
    Li, Qiu
    Mei, Kai
    Xu, Jian-Rong
    Li, Hong-Xia
    Wang, Yong-Sheng
    Wen, Yan-Jun
    Wang, Xiao-Dong
    Yang, Han-Shuo
    Li, Yu-Hua
    Luo, Feng
    Wu, Yang
    Liu, Yan-You
    Yang, Li
    HUMAN GENE THERAPY, 2011, 22 (09) : 1061 - 1069
  • [10] Inhibition of angiogenesis and the growth of murine colon cancer with recombinant human endostatin adenovirus
    Li, Q.
    Wang, L.
    Wen, Y.
    Zhou, J.
    Yang, L.
    Wei, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)